Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Aktiesnakken — November 2009

Planlagt Fastgjort Låst Flyttet Aktiesnakken
14.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • collersteenC Offline
    collersteenC Offline
    collersteen
    wrote on sidst redigeret af
    #10435

    approval in that indication "is not going to change drug practice."

    1 Reply Last reply
    0
    • collersteenC Offline
      collersteenC Offline
      collersteen
      wrote on sidst redigeret af
      #10436

      She said doctors already are getting reimbursed for unapproved cancer treatments listed in national compendia set forth by groups like the N

      1 Reply Last reply
      0
      • collersteenC Offline
        collersteenC Offline
        collersteen
        wrote on sidst redigeret af
        #10437

        like the National Comprehensive Cancer Network, or NCCN.

        1 Reply Last reply
        0
        • collersteenC Offline
          collersteenC Offline
          collersteen
          wrote on sidst redigeret af
          #10438

          dvs. det er der GEN skal smøre for at få gang i noget offlabelsalg?

          1 Reply Last reply
          0
          • collersteenC Offline
            collersteenC Offline
            collersteen
            wrote on sidst redigeret af
            #10439

            og lidt mere..... særlig interessant i lyset af decembers kongres..

            1 Reply Last reply
            0
            • collersteenC Offline
              collersteenC Offline
              collersteen
              wrote on sidst redigeret af
              #10440

              Cancer drugs listed in the national compendia may still be in clinical testing but can be reimbursed by Medicare based on evidence published

              1 Reply Last reply
              0
              • collersteenC Offline
                collersteenC Offline
                collersteen
                wrote on sidst redigeret af
                #10441

                published at meetings like the American Society of Hematology Meeting, which takes place Dec. 5-8.

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  deleted-user
                  wrote on sidst redigeret af
                  #10442

                  det er da ret afgørende...hvorfor og hvordan. Kan Arzerra så blive godkendt eller kan de NETOP blive godkendt og så fjerne hele salget af

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    deleted-user
                    wrote on sidst redigeret af
                    #10443

                    arzerra i CLL???

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      deleted-user
                      wrote on sidst redigeret af
                      #10444

                      og hvorfor fanden er der ingen der har sagt noget.....STINKER, SOLSEN

                      1 Reply Last reply
                      0
                      • D Offline
                        D Offline
                        deleted-user
                        wrote on sidst redigeret af
                        #10445

                        der skulle stå IKKE blive godkendt

                        1 Reply Last reply
                        0
                        • troldmandenT Offline
                          troldmandenT Offline
                          troldmanden
                          wrote on sidst redigeret af
                          #10446

                          coller det er helt nyt for mig at der kan give reimbursment til offlabel indikationer. Så tror da f... amerikanerne kæmper en ullige kamp

                          1 Reply Last reply
                          0
                          • troldmandenT Offline
                            troldmandenT Offline
                            troldmanden
                            wrote on sidst redigeret af
                            #10447

                            De er netop ved at sætte mere fokus på den ullovlige marekdsførring af offlabel indikationer. Myndighederne vil have det stoppet

                            1 Reply Last reply
                            0
                            • troldmandenT Offline
                              troldmandenT Offline
                              troldmanden
                              wrote on sidst redigeret af
                              #10448

                              Og de har lige givet pfizer en bøde på $2 mia for netop at marekdsføre offlabel indikationer

                              1 Reply Last reply
                              0
                              • troldmandenT Offline
                                troldmandenT Offline
                                troldmanden
                                wrote on sidst redigeret af
                                #10449

                                men når man så samtidig giver reimbursment til offlabel....... spørgsmålet er så om den praksis får lov at fortsætte

                                1 Reply Last reply
                                0
                                • D Offline
                                  D Offline
                                  deleted-user
                                  wrote on sidst redigeret af
                                  #10450

                                  hvad var fase 3 resultaterne for ritux?? i cll 1st line

                                  1 Reply Last reply
                                  0
                                  • troldmandenT Offline
                                    troldmandenT Offline
                                    troldmanden
                                    wrote on sidst redigeret af
                                    #10451

                                    her er nogle rituximab fase 3 data http://journals.lww.com/oncology-times/Fulltext/2009/02101/CLL__Phase_III_Studies_Confirm_Added_Rituximab.4.aspx

                                    1 Reply Last reply
                                    0
                                    • D Offline
                                      D Offline
                                      deleted-user
                                      wrote on sidst redigeret af
                                      #10452

                                      det kan være bivirkningerne og det er GREAT news for Arzerra

                                      1 Reply Last reply
                                      0
                                      • D Offline
                                        D Offline
                                        deleted-user
                                        wrote on sidst redigeret af
                                        #10453

                                        hese gains, though, were bought at the price of increased toxicity, with severe hematologic toxicity up from 39% to 55% of patients in the i

                                        1 Reply Last reply
                                        0
                                        • D Offline
                                          D Offline
                                          deleted-user
                                          wrote on sidst redigeret af
                                          #10454

                                          ok ser faktisk de var lunkne allerede dengang

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger